Europe Enteral Nutrition Market Size and Forecast 2021-2031, Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type (Nasogastric, Nasoenteral, Sipping, and Others) and Country

List of Tables

The Europe enteral nutrition market size is projected to reach US$ 5.79 billion by 2031 from US$ 3.32 billion in 2023. The market is expected to register a CAGR of 7.2% during 2023-2031.

Standardized Formulations and Plant-Based Nutrition Products

There is a surge in the demand for products that help consumers proactively manage their health, especially those focused on specific needs in terms of energy levels, immunity, and disease treatment. Functionality and specific formulations of enteral products do not interfere with the existing treatments of patients. The macro-nutrient and micronutrient formulations of enteral nutrition and their applications vary based on the disease under consideration. Isocaloric enteral nutrition formulation (1 kcal/ml) is generally prescribed to achieve estimated or measured caloric goals, while energy-dense formulae (>1 kcal/ml) are prescribed to increase calorie delivery in patients with gastrointestinal dysfunction.

Standardized enteral nutrition products contain fixed constituents and are designed to meet the average nutritional requirements of patients, considering that the requirements differ in different age groups. For example, Peptamen Formula (Nestle) is the only peptide-based formula with enzymatically hydrolyzed 100% whey protein that helps overcome tube-feeding intolerance. Such tube-feeding formulas are specialized enteral nutrition products designed to support absorption and overcome tolerance mechanisms in individuals with gastrointestinal disorders.

A surge in the number of people turning to plant-based food triggers the demand for plant-based nutrition products worldwide. People are becoming increasingly intolerant of artificial/synthetically sourced ingredients used in higher numbers, which may lead to adverse reactions. The Innova Consumer Survey 2020 showed that health, diet variety, sustainability, and taste are among the top reasons why people consider plant-based alternatives. Abbott states that consumers and patients relying on tube feeding also pay much attention to these parameters. Companies in the Europe enteral nutrition market are capitalizing on the growing preference for healthy foods in various demographic groups. As a result, companies such as Kate Farms, Functional Formularies, and Real Food Blends have developed more natural, plant-based enteral products. In August 2021, Kate Farms launched the first closed feeding system delivering plant-based formulas in ready-to-hang bags of 1 L capacity. Kate Farms Standard 1.4 plain and Peptide 1.5 plain formulations are plant-based, organic, calorically dense products that are used as a sole source of supplemental nutrition in tube feeding. In September 2021, Abbott introduced a portfolio of plant-based proteins and organic food ingredients for children and adults.

Therefore, functional, patient-centric formulations and plant-based nutrition products are the prime emerging trends in the Europe enteral nutrition market.

France Enteral Nutrition Market Analysis

According to a Le Monde article published in March 2023, the population share of people aged 60 or more in France is expected to surge from ~20% in 2023 to ~30% by 2050. The number of people aged 85 and above would grow by nearly 90% during 2030-2050. Older adults often experience chronic conditions such as diabetes, cardiovascular diseases, and neurological disorders (e.g., stroke, Parkinson's disease, and Alzheimer's). These conditions can impair the ability to eat normally, leading to malnutrition and requiring enteral feeding. According to the Global Cancer Observatory, France reported 483,568 new cancer cases in 2022, and the number of prevalent cases (5-year) was 1,494,814. Cancer and enteral nutrition are closely connected. Many cancer patients suffer from malnutrition due to the disease itself or the treatments they receive, which can impair their ability to eat and absorb essential nutrients.

Fresenius Kabir France offers a diverse portfolio of ready-to-use enteral nutrition products such as tube feeds, oral nutritional supplements (ONS), and powder products. For patients with dysphagia, the company offers texture-modified products in different consistencies to meet the individual needs of different patients.

Europe Enteral Nutrition Market Report Segmentation Analysis

Key segments that contributed to the derivation of the Europe enteral nutrition market analysis are type, material, and end user.

Based on product type, the Europe enteral nutrition market is segmented into Nasogastric, Nasoenteral, Sipping and Others. The nasogastric segment held the largest share of the market in 2023.

A few prominent players operating in the Europe enteral nutrition market are Nestle, Danone S.A., Abbott Laboratories, Friesland Campina, Fresenius SE and Co. KGaA, B. Braun SE, Dr. Schar AG, Arla Food, Reckitt Benckiser, Perrigo Company PLC, Fonterra Co-operative Group Limited, Kate Farms, and Nutritional Medicinals, LLC among others.

Companies are launching new and innovative products and services to sustain their position in the Europe enteral nutrition market size. In November 2021, Abbott Launched Similac 360 Total Care to Support the Immune System, Digestive Health, and Brain Development. Similac 360 Total Care is the first and only infant formula in the U.S. with a blend of five different HMOs, previously only found together in breast milk. This formula is designed to provide nutrition to support the whole baby's health and development, including the developing immune system, digestive system, and brain.

Product Code: TIPRE00039375

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:

4. Europe Enteral Nutrition Market Landscape

4.1 Overview
4.2 PEST Analysis
4.3 Pricing Analysis
4.4 Pricing Analysis for Sipping Formula
4.5 List of Key Market Players in Top 5 Market
- 4.5.1 Major Market players in Germany, France, United Kingdom

5. Europe Enteral Nutrition Market - Key Market Dynamics

5.1 Europe Enteral Nutrition Market - Key Market Dynamics
5.2 Market Drivers
- 5.2.1 Increasing Prevalence of Gastrointestinal Diseases
- 5.2.2 Rising Cases of Malnutrition and Premature Births
5.3 Market Restraints
- 5.3.1 Mechanical, Gastrointestinal, and Metabolic Complications Associated with Feeding Systems
5.4 Market Opportunities
- 5.4.1 Strategic Initiatives by Key Market Players
5.5 Future Trends
- 5.5.1 Standardized Formulations and Plant-Based Nutrition Products
5.6 Impact of Drivers and Restraints:

6. Europe Enteral Nutrition Market Analysis

6.1 Europe Enteral Nutrition Market Revenue (US$ Million), 2021-2031
6.2 Europe Enteral Nutrition Market Forecast and Analysis
6.3 Enteral and Parenteral Market Value (%)

7. Europe Enteral Nutrition Market Analysis - by Product Type

7.1 Nasogastric
- 7.1.1 Overview
- 7.1.2 Nasogastric: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
- 7.1.3 Standard
  - 7.1.3.1 Overview
  - 7.1.3.2 Standard: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
- 7.1.4 Disease Specific
  - 7.1.4.1 Overview
  - 7.1.4.2 Disease Specific: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
7.2 Nasoenteral
- 7.2.1 Overview
- 7.2.2 Nasoenteral: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
7.3 Sipping
- 7.3.1 Overview
- 7.3.2 Sipping: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
7.4 Others
- 7.4.1 Overview
- 7.4.2 Others: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)

8. Europe Enteral Nutrition Market - Country Analysis

8.1 Europe
- 8.1.1 Europe Enteral Nutrition Market Breakdown by Countries
- 8.1.2 Europe Enteral Nutrition Market Revenue and Forecast and Analysis - by Country
  - 8.1.2.1 Europe Enteral Nutrition Market Revenue and Forecast and Analysis - by Country
  - 8.1.2.2 Germany: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
    - 8.1.2.2.1 Germany: Europe Enteral Nutrition Market Breakdown by Product Type
    - 8.1.2.2.2 Germany: Europe Enteral Nutrition Market Breakdown by Nasogastric Type
    - 8.1.2.2.3 Germany: Europe Enteral Nutrition Market Breakdown by Standard By Calories
    - 8.1.2.2.4 Germany: Europe Enteral Nutrition Market Breakdown by Isocaloric
    - 8.1.2.2.5 Germany: Europe Enteral Nutrition Market Breakdown by Hypercaloric
    - 8.1.2.2.6 Germany: Europe Enteral Nutrition Market Breakdown by Standard By Type
    - 8.1.2.2.7 Germany: Europe Enteral Nutrition Market Breakdown by Standard By End User
  - 8.1.2.3 United Kingdom: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
    - 8.1.2.3.1 United Kingdom: Europe Enteral Nutrition Market Breakdown by Product Type
    - 8.1.2.3.2 United Kingdom: Europe Enteral Nutrition Market Breakdown by Nasogastric Type
    - 8.1.2.3.3 United Kingdom: Europe Enteral Nutrition Market Breakdown by Standard By Calories
    - 8.1.2.3.4 United Kingdom: Europe Enteral Nutrition Market Breakdown by Isocaloric
    - 8.1.2.3.5 United Kingdom: Europe Enteral Nutrition Market Breakdown by Hypercaloric
    - 8.1.2.3.6 United Kingdom: Europe Enteral Nutrition Market Breakdown by Standard By Type
    - 8.1.2.3.7 United Kingdom: Europe Enteral Nutrition Market Breakdown by Standard By End User
  - 8.1.2.4 France: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
    - 8.1.2.4.1 France: Europe Enteral Nutrition Market Breakdown by Product Type
    - 8.1.2.4.2 France: Europe Enteral Nutrition Market Breakdown by Nasogastric Type
    - 8.1.2.4.3 France: Europe Enteral Nutrition Market Breakdown by Standard By Calories
    - 8.1.2.4.4 France: Europe Enteral Nutrition Market Breakdown by Isocaloric
    - 8.1.2.4.5 France: Europe Enteral Nutrition Market Breakdown by Hypercaloric
    - 8.1.2.4.6 France: Europe Enteral Nutrition Market Breakdown by Standard By Type
    - 8.1.2.4.7 France: Europe Enteral Nutrition Market Breakdown by Standard By End User
  - 8.1.2.5 Italy: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
    - 8.1.2.5.1 Italy: Europe Enteral Nutrition Market Breakdown by Product Type
    - 8.1.2.5.2 Italy: Europe Enteral Nutrition Market Breakdown by Nasogastric Type
    - 8.1.2.5.3 Italy: Europe Enteral Nutrition Market Breakdown by Standard By Calories
    - 8.1.2.5.4 Italy: Europe Enteral Nutrition Market Breakdown by Isocaloric
    - 8.1.2.5.5 Italy: Europe Enteral Nutrition Market Breakdown by Hypercaloric
    - 8.1.2.5.6 Italy: Europe Enteral Nutrition Market Breakdown by Standard By Type
    - 8.1.2.5.7 Italy: Europe Enteral Nutrition Market Breakdown by Standard By End User
  - 8.1.2.6 Spain: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
    - 8.1.2.6.1 Spain: Europe Enteral Nutrition Market Breakdown by Product Type
    - 8.1.2.6.2 Spain: Europe Enteral Nutrition Market Breakdown by Nasogastric Type
    - 8.1.2.6.3 Spain: Europe Enteral Nutrition Market Breakdown by Standard By Calories
    - 8.1.2.6.4 Spain: Europe Enteral Nutrition Market Breakdown by Isocaloric
    - 8.1.2.6.5 Spain: Europe Enteral Nutrition Market Breakdown by Hypercaloric
    - 8.1.2.6.6 Spain: Europe Enteral Nutrition Market Breakdown by Standard By Type
    - 8.1.2.6.7 Spain: Europe Enteral Nutrition Market Breakdown by Standard By End User
  - 8.1.2.7 Czech Republic: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
    - 8.1.2.7.1 Czech Republic: Europe Enteral Nutrition Market Breakdown by Product Type
    - 8.1.2.7.2 Czech Republic: Europe Enteral Nutrition Market Breakdown by Nasogastric Type
    - 8.1.2.7.3 Czech Republic: Europe Enteral Nutrition Market Breakdown by Standard By Calories
    - 8.1.2.7.4 Czech Republic: Europe Enteral Nutrition Market Breakdown by Isocaloric
    - 8.1.2.7.5 Czech Republic: Europe Enteral Nutrition Market Breakdown by Hypercaloric
    - 8.1.2.7.6 Czech Republic: Europe Enteral Nutrition Market Breakdown by Standard By Type
    - 8.1.2.7.7 Czech Republic: Europe Enteral Nutrition Market Breakdown by Standard By End User
  - 8.1.2.8 Rest of Europe: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
    - 8.1.2.8.1 Rest of Europe: Europe Enteral Nutrition Market Breakdown by Product Type
    - 8.1.2.8.2 Rest of Europe: Europe Enteral Nutrition Market Breakdown by Nasogastric Type
    - 8.1.2.8.3 Rest of Europe: Europe Enteral Nutrition Market Breakdown by Standard By Calories
    - 8.1.2.8.4 Rest of Europe: Europe Enteral Nutrition Market Breakdown by Isocaloric
    - 8.1.2.8.5 Rest of Europe: Europe Enteral Nutrition Market Breakdown by Hypercaloric
    - 8.1.2.8.6 Rest of Europe: Europe Enteral Nutrition Market Breakdown by Standard By Type
    - 8.1.2.8.7 Rest of Europe: Europe Enteral Nutrition Market Breakdown by Standard By End User

9. Industry Landscape

9.1 Overview
9.2 Growth Strategies in Europe Enteral Nutrition Market
9.3 Organic Growth Strategies
- 9.3.1 Overview
9.4 Inorganic Growth Strategies
- 9.4.1 Overview

10. Company Profiles

10.1 Nestle SA
- 10.1.1 Key Facts
- 10.1.2 Business Description
- 10.1.3 Products and Services
- 10.1.4 Financial Overview
- 10.1.5 SWOT Analysis
- 10.1.6 Key Developments
10.2 Danone SA
- 10.2.1 Key Facts
- 10.2.2 Business Description
- 10.2.3 Products and Services
- 10.2.4 Financial Overview
- 10.2.5 SWOT Analysis
- 10.2.6 Key Developments
10.3 Abbott Laboratories
- 10.3.1 Key Facts
- 10.3.2 Business Description
- 10.3.3 Products and Services
- 10.3.4 Financial Overview
- 10.3.5 SWOT Analysis
- 10.3.6 Key Developments
10.4 Royal FrieslandCampina NV
- 10.4.1 Key Facts
- 10.4.2 Business Description
- 10.4.3 Products and Services
- 10.4.4 Financial Overview
- 10.4.5 SWOT Analysis
- 10.4.6 Key Developments
10.5 Fresenius SE & Co KGaA
- 10.5.1 Key Facts
- 10.5.2 Business Description
- 10.5.3 Products and Services
- 10.5.4 Financial Overview
- 10.5.5 SWOT Analysis
- 10.5.6 Key Developments
10.6 B Braun SE
- 10.6.1 Key Facts
- 10.6.2 Business Description
- 10.6.3 Products and Services
- 10.6.4 Financial Overview
- 10.6.5 SWOT Analysis
- 10.6.6 Key Developments
10.7 Reckitt Benckiser Group Plc
- 10.7.1 Key Facts
- 10.7.2 Business Description
- 10.7.3 Products and Services
- 10.7.4 Financial Overview
- 10.7.5 SWOT Analysis
- 10.7.6 Key Developments
10.8 Kate Farms Inc
- 10.8.1 Key Facts
- 10.8.2 Business Description
- 10.8.3 Products and Services
- 10.8.4 Financial Overview
- 10.8.5 SWOT Analysis
- 10.8.6 Key Developments
10.9 Dr Schar AG
- 10.9.1 Key Facts
- 10.9.2 Business Description
- 10.9.3 Products and Services
- 10.9.4 Financial Overview
- 10.9.5 SWOT Analysis
- 10.9.6 Key Developments
10.10 Fonterra Co-Operative Group Ltd
- 10.10.1 Key Facts
- 10.10.2 Business Description
- 10.10.3 Products and Services
- 10.10.4 Financial Overview
- 10.10.5 SWOT Analysis
- 10.10.6 Key Developments
10.11 Arla Foods amba
- 10.11.1 Key Facts
- 10.11.2 Business Description
- 10.11.3 Products and Services
- 10.11.4 Financial Overview
- 10.11.5 SWOT Analysis
- 10.11.6 Key Developments
10.12 Perrigo Co Plc
- 10.12.1 Key Facts
- 10.12.2 Business Description
- 10.12.3 Products and Services
- 10.12.4 Financial Overview
- 10.12.5 SWOT Analysis
- 10.12.6 Key Developments
10.13 Charing Cross Scientific AS
- 10.13.1 Key Facts
- 10.13.2 Business Description
- 10.13.3 Products and Services
- 10.13.4 Financial Overview
- 10.13.5 SWOT Analysis
- 10.13.6 Key Developments
10.14 Bexen Medical
- 10.14.1 Key Facts
- 10.14.2 Business Description
- 10.14.3 Products and Services
- 10.14.4 Financial Overview
- 10.14.5 SWOT Analysis
- 10.14.6 Key Developments

11. Appendix

11.1 About The Insight Partners
11.2 Glossary of Terms